Andrew Zaleski is a journalist outside Washington D.C.
Andrew Zaleski is a journalist outside Washington D.C.
Unity Biotechnology is one of a slew of companies taking part in the zeitgeist of aging research. The company, backed by Jeff Bezos and Peter Thiel, is focused on designing drugs and treatments that stop diseases related to aging.
Unity Biotechnology is one of a slew of companies taking part in the zeitgeist of aging research. The company, backed by Jeff Bezos and Peter Thiel, is focused on designing drugs and treatments that stop diseases related to aging.
Bill Gates is investing in Ginkgo Bioworks, a Boston-based start-up that prints synthetic DNA from a computer and is developing one of the world's largest libraries of usable designer genetic code.
Insightec, an Israeli company backed by the Koch brothers, has developed an ultrasound technology to treat tremors and Parkinson's disease.
Luxembourg, a leader in satellite communications, aims to be a hub for asteroid mining companies. It has put a regulatory framework in place to attract space start-ups.
The technology stock market in Israel is booming, and now there's an ETF for investors to identify growing companies that could break out.
Hospitals are using AI chatbots to help geriatric patients face the end of life. And they may be better at talking death than doctors.
To fast-forward development of breakthrough defense technology Lockheed Martin is investing in start-ups through its Lockheed Martin Ventures fund.
Copycat businesses can work and become hugely successful. Here are popular brands that got their start by imitating a disruptor.
New visual tools, like eSight3 glasses, help the visually impaired see using HD cameras and video displays placed on the wearer's eyes.
Data also provided by 
